Cited 38 time in
Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Han, Sun-Young | - |
| dc.contributor.author | Choi, Jie Won | - |
| dc.contributor.author | Yang, Jeon | - |
| dc.contributor.author | Chae, Chong Hack | - |
| dc.contributor.author | Lee, Jongkook | - |
| dc.contributor.author | Jung, Heejung | - |
| dc.contributor.author | Lee, Kwangho | - |
| dc.contributor.author | Ha, Jae Du | - |
| dc.contributor.author | Kim, Hyoung Rae | - |
| dc.contributor.author | Cho, Sung Yun | - |
| dc.date.accessioned | 2022-12-27T01:48:32Z | - |
| dc.date.available | 2022-12-27T01:48:32Z | - |
| dc.date.issued | 2012-04 | - |
| dc.identifier.issn | 0960-894X | - |
| dc.identifier.issn | 1464-3405 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/22223 | - |
| dc.description.abstract | A series of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones have been identified as a new class of VEGFR-2 kinase inhibitors. A variety of (4,5,6,7-tetrahydro-imidazo[5,4-c]pyridin-2-yl)-acetic acid ethyl esters were synthesized, and their VEGFR-2 inhibitory activity was evaluated. Described herein are the preparation of the series and the effects of the compounds on VEGFR-2 kinase activity. (C) 2012 Elsevier Ltd. All rights reserved. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Pergamon Press Ltd. | - |
| dc.title | Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1016/j.bmcl.2012.02.073 | - |
| dc.identifier.scopusid | 2-s2.0-84862783839 | - |
| dc.identifier.wosid | 000302768200041 | - |
| dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, v.22, no.8, pp 2837 - 2842 | - |
| dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
| dc.citation.volume | 22 | - |
| dc.citation.number | 8 | - |
| dc.citation.startPage | 2837 | - |
| dc.citation.endPage | 2842 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
| dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
| dc.subject.keywordPlus | ORAL MULTIKINASE INHIBITOR | - |
| dc.subject.keywordPlus | CANCER-THERAPY | - |
| dc.subject.keywordPlus | ANGIOGENESIS | - |
| dc.subject.keywordPlus | BEVACIZUMAB | - |
| dc.subject.keywordPlus | PHARMACOKINETICS | - |
| dc.subject.keywordPlus | NAPHTHAMIDES | - |
| dc.subject.keywordPlus | RECEPTORS | - |
| dc.subject.keywordPlus | SUNITINIB | - |
| dc.subject.keywordPlus | ANTIBODY | - |
| dc.subject.keywordAuthor | Cancer | - |
| dc.subject.keywordAuthor | VEGFR-2 | - |
| dc.subject.keywordAuthor | KDR kinase | - |
| dc.subject.keywordAuthor | Imidazo[4,5-c]pyridine | - |
| dc.subject.keywordAuthor | Quinolin-2-one | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
